Handelsbanken Fonder Ab Cara Therapeutics, Inc. Transaction History

Handelsbanken Fonder Ab

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	SELL	$7.45 - $13.84 $36,505 - $67,816	-4,900 Reduced 31.61%	10,600 $97,000
Q2 2021 Aug 03, 2021	BUY	$12.38 - $29.19 $191,890 - $452,445	15,500 New	15,500 $221,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $262M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.